Development of nanosponges from erythrocyte ghosts for removal of streptolysin-O from mammalian blood. (November 2016)

• Record Type: Journal Article
• Authors: Chhabria, Vikesh; Beeton, Steve
• Is Part Of: Nanomedicine. Volume 11:Number 21(2016)
• Page Start: 2797
• Page End: 2807
• Publication Date: 2016-11
• Subjects: biomimetic -- erythrocyte ghost -- nanoparticle -- nanosponges -- streptolysin-O -- toxin absorption; Nanotechnology -- Periodicals; Medical technology -- Periodicals; Nanotechnology -- Therapeutic use -- Periodicals; 610.28
• DOI: 10.2217/nnm-2016-0180
• Languages: English
• ISSNs: 1743-5889

Abstract

Aim: To produce mammalian biomimetic nanosponges from mammalian erythrocyte ghosts. Biomimetic nanosponges were studied in vitro as treatment platforms against exotoxin-related sepsis.Methods: Ovine blood was treated with hypotonic buffer to create erythrocyte ghosts and then subjected to sonication to produce erythrocyte vesicles of nonuniform size. Vesicles were then serially extruded through 400-nm and 100-nm polycarbonate membranes. Nanosponges were prepared by fusing poly(d, l -lactic-co-glycolic acid) cores with ovine erythrocyte vesicles.Results: Ovine erythrocytes were the most susceptible to streptolysin-O lysis, making it a model to study sepsis treatment. Ovine nanosponges adsorbed streptolysin-O at 37 and 40°C.Conclusion: These results identify ovine nanosponges as novel therapeutic model to test adsorption of cholesterol binding toxins such as streptolysin-O.